Completed PHASE4 INTERVENTIONAL 2-arm NCT03502642

Ropivacaine Continuous Wound Infusion Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Delivery

Ropivacaine Continuous Wound Infusion Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Delivery : A Randomized Controlled Trial

Sponsor: LEVENTON

Conditions Obstetric Pain

Interventions Normal saline Ropivacaine (Ropivacaina Molteni®) Spinal Anesthesia intrathecal morphine wound infusion (Dosi-Pain® Kit, LEVENTON SAU, Spain)

Updated 6 times since 2018 Last updated: Oct 8, 2018 Started: May 29, 2017 Primary completion: May 29, 2018 Completion: Jun 29, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Obstetric Pain, this trial is completed. The trial is conducted by LEVENTON and has accumulated 6 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Nov 2018 — Jan 2021 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Jun 2018 — Nov 2018 [monthly]

Recruiting PHASE4

▶ Show 1 earlier version

May 2018 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

May 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

LEVENTON
Saint-Joseph University

Data source: Saint-Joseph University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beirut, Lebanon